4Vote!
PR News Wire (Free subscription) | 11/24/2009
SAN DIEGO, Nov. 24, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 at 11:30 a.m. Eastern Time (8:30 a.m. Pacific Time) at the New York Palace Hotel in New York City. Jack Lief, Arena's President and Chief Executive Officer, is...
+Vote!
Stockpreacher Penny Stock Blog (Free subscription) | 11/18/2009
Arena Pharmaceuticals Inc. (NASDAQ: ARNA) Arena Pharmaceuticals Inc. (ARNA) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. The Company’s drug candidate, lorcaserin hydrochloride (lorcaserin), is being...
5Vote!
Red Orbit (Free subscription) | 11/10/2009
SAN DIEGO, Nov. 9, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc.
3Vote!
GuruFocus Updates (Free subscription) | 11/10/2009
By 10qk. Arena Pharmaceuticals Inc. ( ARNA ) filed Quarterly Report for the period ended 2009-09-30. Read more » »
5Vote!
PR News Wire (Free subscription) | 11/10/2009
SAN DIEGO, Nov. 9, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today reported financial results for the third quarter ended September 30, 2009.
4Vote!
Life Science World (Free subscription) | 11/10/2009
[NEWS] SAN DIEGO, Nov. 9, 2009 /PRNewswire-FirstCall/ — Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today reported financial results for the third quarter ended September 30, 2009. Arena reported a lower net loss allocable to common stockholders in the third quarter of 2009 of $34.8 million, or $0.38 per share, compared to a net loss allocable to common stockholders in the third...
5Vote!
Red Orbit (Free subscription) | 11/04/2009
SAN DIEGO, Nov. 4, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced it will report third quarter 2009 financial results after the NASDAQ Global Market closes on Monday, November 9, 2009.
4Vote!
PR News Wire (Free subscription) | 11/04/2009
SAN DIEGO, Nov. 4, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced it will report third quarter 2009 financial results after the NASDAQ Global Market closes on Monday, November 9, 2009. The next morning, November 10, 2009, Jack Lief, Arena's President and Chief Executive Officer, and Robert E. Hoffman, Arena's Vice President, Finance and Chief...
4Vote!
PR News Wire (Free subscription) | 10/27/2009
WASHINGTON, Oct. 27, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced...
7Vote!
Wall Street Pit (Free subscription) | 11/09/2009
» Look for the following companies to release earnings After the Close today - Monday Nov 9: Arena Pharmaceuticals, Inc. (ARNA) Abraxas Petroleum Corp. (AXAS) ACADIA Pharmaceuticals, Inc. (ACAD) Advanced Photonix Inc. (API) Advocat Inc. (AVCA) Alexza Pharmaceuticals Inc. (ALXA) ...
4Vote!
Stock Market Analysis (Free subscription) | 11/04/2009
Below is a list of some of the largest stock gainers and losers so far in pre market for November 4, 2009. Check out my Hot Stocks to Watch page for the latest updates. Pre Market Stock Gainers - 11/4/09 GenVec Inc. (GNVC) - FDA GRANTS ORPHAN DRUG DESIGNATION FOR TNFERADE™ Thomas Properties Group Inc. (TPGI) - Thomas Properties Group, Inc. Announces Postponement of Common...
4Vote!
Market Wire (Free subscription) | 11/04/2009
NEW DELHI, INDIA (MARKET WIRE) Wallstsense.com is an online community with a dedicated team of analysts who are providing free in-depth research on North American equities. Our analysts have issued complimentary analysis on the following six companies: Pulte Homes Inc. (NYSE: PHM), PPL Corporation (NYSE: PPL), Ruby Tuesday Inc. (NYSE: RT), Rite Aid Corp. (NYSE: RAD), Arena Pharmaceuticals...
3Vote!
Sify (Free subscription) | 10/26/2009
Shares of Arena Pharmaceuticals Inc. traded higher Monday after the company reported new clinical trial data for its experimental obesity drug lorcaserin.
3Vote!
Sify (Free subscription) | 10/26/2009
Shares of Arena Pharmaceuticals Inc. traded higher Monday after the company reported new clinical trial data for its experimental obesity drug lorcaserin.
4Vote!
Miami Herald (Free subscription) | 10/26/2009
Shares of Arena Pharmaceuticals Inc. traded higher Monday after the company reported new clinical trial data for its experimental obesity drug lorcaserin.
